secwatch.observer — SEC 8-K summary
======================================

Issuer:     KYNTRA BIO, INC. (KYNB)
CIK:        0000921299
Form:       8-K
Filed at:   2021-08-16T23:59:59+00:00
Accession:  0001564590-21-044718
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroGen announces CFO retirement of Pat Cotroneo; Juan Graham appointed effective Sept 7, 2021
--------------------------------------------------------------------------------

- Pat Cotroneo retires after 21 years; will serve as Executive Advisor to CEO through March 2022.
- Juan Graham becomes CFO Sept 7, 2021; previously Global CFO/VP Finance Supply Chain at Johnson & Johnson.
- Graham receives $470k base salary, 50% target bonus, 196k stock options, 35k RSUs, and up to $300k signing bonus.
- Relocation assistance up to $100k (grossed up) and eligibility for change-in-control severance agreement.
- No family relationships or related-party transactions disclosed with Mr. Graham.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921299/000156459021044718/0001564590-21-044718-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921299/000156459021044718/fgen-8k_20210814.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-044718

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer